| 000 | 01777 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515170958.0 | ||
| 264 | 0 | _c20091019 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1521-009X | ||
| 024 | 7 |
_a10.1124/dmd.109.026781 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPellegatti, Mario | |
| 245 | 0 | 0 |
_aDisposition and metabolism of radiolabeled casopitant in humans. _h[electronic resource] |
| 260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cAug 2009 |
||
| 300 |
_a1635-45 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aFeces _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolomics _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 | _aSpectrometry, Mass, Electrospray Ionization |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aBordini, Ellenia | |
| 700 | 1 | _aFizzotti, Patrizia | |
| 700 | 1 | _aRoberts, Andy | |
| 700 | 1 | _aJohnson, Brendan M | |
| 773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 37 _gno. 8 _gp. 1635-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/dmd.109.026781 _zAvailable from publisher's website |
| 999 |
_c18848730 _d18848730 |
||